How to perform chemotherapy for thyroid cancer? What are the commonly used chemotherapy regimens for thyroid cancer?

It is better to combine Chinese and Western medicine. Western medicine treats symptoms while Chinese medicine treats the root cause. Western medicine combined with Qi'ao brand yew Chinese medicinal materials has a very good therapeutic effect. Qi'ao yew achieves the therapeutic effect by preventing the replication of cancer cells. Chemotherapy is also acceptable.

At the same time, chemotherapy for thyroid cancer is a treatment method for thyroid cancer, but thyroid cancer is not very sensitive to chemotherapy, especially for patients with advanced tumors or weak bodies. Blind use of chemotherapy may not achieve the expected effect, and will not only lead to rapid deterioration of the disease, but also accelerate the death of the patient. In the late stage, the patient's survival period can be extended through comprehensive treatment, and combined with the use of 16.2% ginsenoside Rh2 (life-protecting element), it can improve the autoimmune function of critically ill patients in the late stage, control the progression of the disease, improve the condition of physical weakness and mental depression, relieve the patient's pain and other symptoms, promote the improvement of the patient's appetite and sleep, prolong life, and increase the hope of recovery.

The chemotherapy regimen for thyroid cancer is related to the type of thyroid cancer and the condition of the disease. Thyroid cancer is not sensitive to chemotherapy, and surgery is the first choice if it can be treated. After surgery, anti-tumor Chinese medicine can be taken to further consolidate the therapeutic effect, improve immunity, strengthen physical fitness, and prevent recurrence and metastasis on the basis of killing tumors.

However, as mentioned above, thyroid cancer is not very responsive to chemotherapy, so there are also the following methods:

1.pa plan

DDP 40mg/m2, intravenous injection;

adm60mg/m2, intravenous injection;

Once every 3 weeks. The remission rate is 83%.

2. FMA solution

5-fu 500 mg/m2, intravenous injection, on days 1 and 8;

MMC 40 mg/m2, intravenous injection, on the 1st and 8th days;

ADM 30 mg/m2, intravenous injection, on the 3rd and 14th days.

Repeat every 5 weeks. The remission rate was 32%.